Theranostic application of Lipiodol for transarterial chmoembolization in a VX2 tumor animal model
J.M.M. van Breugel1; J. Chapiro, MD1; S. Mirpour2; X. Zhang3; M. Lin, PhD1; M.A. Miszczuk1; E. Liapi2; J.F. Geschwind, MD1
The most commonly used TACE protocol is based on lipiodol. However, the evidence supporting this technique is more than a decade old and technical advances have meanwhile enabled a more specific TACE with the ability to embolize super-selectively under precision image guidance. Knowledge on lipiodol-based TACE should therefore be updated.
Aim: To establish and validate the role of Lipiodol as a tumor-seeking, theranostic agent and specific imaging biomarker for tumor tissue after transarterial chemoembolization (TACE) in an animal tumor model for liver cancer.